Try our Advanced Search for more refined results

Pa. High Court Nixes Teva Appeal In Reglan Preemption Fight

By Kurt Orzeck (September 17, 2014, 8:31 PM EDT) -- The Pennsylvania Supreme Court on Wednesday rejected an appeal by Teva Pharmaceuticals USA Inc. and other generic drugmakers battling a lower court's ruling that product liability claims of thousands of generic Reglan users weren't necessarily preempted by federal law, allowing their suits over the digestive drug to proceed....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!